Published in Pharmaceuticals (Basel) on June 19, 2012
Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. BMJ (2002) 5.36
Mechanism of adenylate cyclase activation by cholera toxin: inhibition of GTP hydrolysis at the regulatory site. Proc Natl Acad Sci U S A (1977) 4.63
Single-dose azithromycin for the treatment of cholera in adults. N Engl J Med (2006) 3.75
Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet (1994) 3.62
The proteolytic systems of lactic acid bacteria. Antonie Van Leeuwenhoek (1996) 3.50
Field trial of oral cholera vaccines in Bangladesh. Lancet (1986) 2.85
Role of cholera a toxin in experimental cholera. J Bacteriol (1959) 2.79
Antibiotic therapy of cholera. Bull World Health Organ (1967) 2.73
The high burden of cholera in children: comparison of incidence from endemic areas in Asia and Africa. PLoS Negl Trop Dis (2008) 2.36
Public health. The cholera crisis in Africa. Science (2009) 2.02
Protection from gastrointestinal diseases with the use of probiotics. Am J Clin Nutr (2001) 1.92
A recombinant probiotic for treatment and prevention of cholera. Gastroenterology (2006) 1.64
Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG. Ann Nutr Metab (1996) 1.53
Ability of dairy strains of lactic acid bacteria to bind a common food carcinogen, aflatoxin B1. Food Chem Toxicol (1998) 1.52
Intestinal electrolyte transport and diarrheal disease (1). N Engl J Med (1989) 1.51
Probiotic bifidobacteria protect mice from lethal infection with Shiga toxin-producing Escherichia coli O157:H7. Infect Immun (2004) 1.48
Surface binding of aflatoxin B(1) by lactic acid bacteria. Appl Environ Microbiol (2001) 1.37
Multicentric study of the effect of milk fermented by Lactobacillus casei on the incidence of diarrhoea. Int J Clin Pract (2000) 1.36
Clinical indications for probiotics: an overview. Clin Infect Dis (2008) 1.32
Probiotics and human health: a clinical perspective. Postgrad Med J (2004) 1.23
Single-dose doxycycline for cholera. Antimicrob Agents Chemother (1978) 1.05
An old enemy returns. Bull World Health Organ (2009) 1.04
Selective in vitro binding of dietary mutagens, individually or in combination, by lactic acid bacteria. Food Addit Contam (2002) 0.93
The subunits of cholera toxin: structure, stoichiometry, and function. J Infect Dis (1976) 0.91
Removal of microcystin-LR by strains of metabolically active probiotic bacteria. FEMS Microbiol Lett (2007) 0.90
Characterization of microcystin-LR removal process in the presence of probiotic bacteria. Toxicon (2011) 0.84
Characterisation of cholera toxin by liquid chromatography--electrospray mass spectrometry. Toxicon (1999) 0.82
Removal of the cyanobacterial toxin microcystin-LR by human probiotics. Toxicon (2005) 0.81
Similar bifidogenic effects of prebiotic-supplemented partially hydrolyzed infant formula and breastfeeding on infant gut microbiota. FEMS Immunol Med Microbiol (2005) 1.27
Comparative cellular toxicity of hydrophilic and hydrophobic microcystins on Caco-2 cells. Toxins (Basel) (2012) 0.99
Probiotics modulate the Bifidobacterium microbiota of elderly nursing home residents. Age (Dordr) (2008) 0.99
Probiotic bacteria in the management of atopic disease: underscoring the importance of viability. J Pediatr Gastroenterol Nutr (2003) 0.99
Comparison of four methods to enumerate probiotic bifidobacteria in a fermented food product. Food Microbiol (2005) 0.95
Probiotic supplementation reduces a biomarker for increased risk of liver cancer in young men from Southern China. Am J Clin Nutr (2006) 0.91
Removal of microcystin-LR by strains of metabolically active probiotic bacteria. FEMS Microbiol Lett (2007) 0.90
Probiotic bacteria may become dormant during storage. Appl Environ Microbiol (2005) 0.90
Prenatal probiotic administration can influence Bifidobacterium microbiota development in infants at high risk of allergy. J Allergy Clin Immunol (2009) 0.87
Interaction between microcystins of different hydrophobicities and lipid monolayers. Toxicon (2003) 0.86
Eiders (Somateria mollissima) obtain nodularin, a cyanobacterial hepatotoxin, in Baltic Sea food web. Environ Toxicol Chem (2004) 0.84
Specific strains of probiotic bacteria are efficient in removal of several different cyanobacterial toxins from solution. Toxicon (2008) 0.83
Production and sedimentation of peptide toxins nodularin-R and microcystin-LR in the northern Baltic Sea. Environ Pollut (2008) 0.83
Analysis of nodularin-R in eider (Somateria mollissima), roach (Rutilus rutilus L.), and flounder (Platichthys flesus L.) liver and muscle samples from the western Gulf of Finland, northern Baltic Sea. Environ Toxicol Chem (2006) 0.82
Trophic transfer of cyanobacterial toxins from zooplankton to planktivores: consequences for pike larvae and mysid shrimps. Environ Toxicol (2005) 0.81
Specific Bifidobacterium strains isolated from elderly subjects inhibit growth of Staphylococcus aureus. Int J Food Microbiol (2007) 0.81
Accumulation and effects of nodularin from a single and repeated oral doses of cyanobacterium Nodularia spumigena on flounder (Platichthys flesus L.). Arch Environ Contam Toxicol (2008) 0.79
Oxidation of the cyanobacterial hepatotoxin microcystin-LR by chlorine dioxide: reaction kinetics, characterization, and toxicity of reaction products. Environ Sci Technol (2004) 0.78
Intrinsic properties of so-called dormant probiotic bacteria, determined by flow cytometric viability assays. Appl Environ Microbiol (2006) 0.78
Quantitative LC-ESI-MS analyses of microcystins and nodularin-R in animal tissue--matrix effects and method validation. Environ Toxicol (2005) 0.75
Production of antibodies against microcystin-RR for the assessment of purified microcystins and cyanobacterial environmental samples. Toxicon (2006) 0.75
Effect of glucose in removal of microcystin-LR by viable commercial probiotic strains and strains isolated from dadih fermented milk. J Agric Food Chem (2008) 0.75
Analytical Methods Workgroup report. Adv Exp Med Biol (2008) 0.75
Oxidation of the cyanobacterial hepatotoxin microcystin-LR by chlorine dioxide: influence of natural organic matter. Environ Sci Technol (2006) 0.75